COVID-19 and vascular diseaseImpact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program
Under an Elsevier user license
open archive
Key words
Chronic limb threatening ischemia
COVID-19
Decision support
Medical decision making
Triage
Cited by (0)
Author conflict of interest: J.A.S. is a member of the Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by GlaxoSmithKline, Novo Nordisk, AstraZeneca, and Eli Lilly and has also received institutional research funding from Loxo/Lilly and Exelixis. E.M.L., B.W., J.I., A.O., W.G., S.V., E.W., J.H., C.E., E.L., A.R., L.R., and M.S.C. have no conflicts of interest.
The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
© 2020 by the Society for Vascular Surgery. Published by Elsevier Inc.